Many people who take GLP-1 drugs find that their cravings disappear. I went to a Buddhist monastery to understand why that ...

“As consumers are becoming more health conscious, this could lead to a potential decrease in consumption of confectionery,” ...

I highlight potential of Biomea Fusion's diabetes drug amid competition, advises caution with stock due to risks. Read more ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences. Review: ...

Securing a prescription for GLP-1s can be pricey — and not to mention, sometimes quite frustrating and invasive. But safety ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A newly published clinical study indicates that a polyphenol-rich botanical composition of lemon verbena and hibiscus can ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Highlights,The GLP-1 market for obesity and diabetes treatments is gaining momentum, with Novo Nordisk and Eli Lilly leading ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

IMPACT trial is evaluating the safety and efficacy of pemvidutide in approximately 190 subjects with MASH; top-line efficacy data expected in Q2 2025 End-of-Phase 2 Meeting for the obesity program ...